A continuación encontrará estudios de casos, seminarios web, blogs y comunicados de prensa en los que compartimos información valiosa sobre los ensayos clínicos descentralizados.
Digital transformation is reshaping nearly every industry, and clinical trials are no exception. As technology plays a bigger role in healthcare, patients are demanding more access to medical research. It’s not just patients who are asking for more: Medical professionals, researchers, and pharmaceutical companies all want to improve quality, efficiency, and access to clinical trials.
Clinical trial sponsors are constantly seeking ways to collect better data, faster—accelerating clinical trials. Meanwhile, patients are increasingly likely to access healthcare services and interact with healthcare professionals digitally. Growing usage of telehealth also impacts patients’ expectations of clinical trials, with convenience and accessibility taking center stage.
In this post, we provide a comprehensive breakdown of the key challenges and opportunities associated with virtual clinical trials, examining the nuances of virtual components and how their implementation might affect each stage and touchpoint of the clinical trial journey.
ObvioHealth highlight the benefits of incorporating DCTs, as well as the challenges associated with DCTs, and call out specific use cases for DCTs.
Hybrid clinical trials drive efficiency, engagement, and effectiveness in clinical research. See whether a hybrid model could be a fit for your upcoming study.